Clinical Trials Browser

Phase 1 × INDUSTRY × ARX788 × Clear all

NCT03255070 2024-02-01

A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT02512237 2020-06-05

A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 Expression

Phase 1 Terminated

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms